skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Daniel

+3 year(s) experience

Maintaining the CNS, autoimmune and ophthalmology drug records in the Pharmaprojects database. Review and provide guidance on primary research conducted by editors. Provide tailored advice and support to subscribed clients on finding information on drug development from Pharmaprojects.

Maintaining the CNS, autoimmune and ophthalmology drug records in the Pharmaprojects database. Review and provide guidance on primary research conducted by editors. Provide tailored advice and support to subscribed clients on finding information on drug development from Pharmaprojects.


Analyst Articles

Articles by Daniel

  • Trialtrove, Pharmaprojects

    2018 - the year of successful migraine prophylaxis therapies

    2018 - the year of successful migraine prophylaxis therapies

    It is essential that a truly effective prophylactic migraine medicine is found. Many currently available migraine therapies are acute and provide the patient with some relief after the onset of a migraine, whereas preventative medicines are extremely limited and not entirely effective. This blog will look at the past, present, and future of migraine prophylaxis.

    Topic Drug development landscape